WOBURN, Mass.--(BUSINESS WIRE)--Kapa Biosystems, a provider of next-generation engineered polymerases, announced the adoption of its KAPA2G™ Fast HotStart DNA Polymerase by industry and academic leaders in the fields of resequencing and SNP detection including Agencourt Bioscience, a Beckman Coulter Company, energy crop company Ceres, Inc., Memorial Sloan Kettering Cancer Center and the NIH Intramural Sequencing Center (NISC).
